Features Screener Stocks Charts
Sign In Sign Up

Sanofi India Cash Flow Statement

NSE:SANOFI | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

Cash Flow Insights

Cash Conversion

0.82x

SANOFI's operating cash flow covered 82% of net income in FY 2024. Some earnings may be tied up in working capital.

Free Cash Flow

₹4.25B

SANOFI's free cash flow was ₹4.25B in FY 2024, up 116.8% from FY 2023.

Dividend Coverage

1.1x

SANOFI's free cash flow covered dividends 1.1x in FY 2024 but leaves limited surplus.

CapEx Intensity

7.9%

Capital expenditure was 7.9% of operating cash flow in FY 2024 for SANOFI, indicating a capital-light business.

2-year SANOFI cash flow snapshot

Hover the chart icon for YoY change.

FY 2023 - FY 2024
Item Chart 2023 2024
Net Income 8.46B 5.62B
Cash flow Operating Activities 2.30B 4.62B
Investments in PPE -343.00M -364.00M
Cash flow Investing Activities 375.00M -192.00M
Dividend Paid -8.68B -3.85B
Cash flow Financing Activities -8.78B -3.92B
Cash at beginning of period 10.05B 3.95B
Cash at end of period 3.95B 2.84B
Free Cash Flow 1.96B 4.25B

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹).

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Dec-2024